ATEC vs. IART, ATRC, OFIX, OSUR, TCMD, GMED, LMAT, NVCR, ICUI, and NARI
Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include Integra LifeSciences (IART), AtriCure (ATRC), Orthofix Medical (OFIX), OraSure Technologies (OSUR), Tactile Systems Technology (TCMD), Globus Medical (GMED), LeMaitre Vascular (LMAT), NovoCure (NVCR), ICU Medical (ICUI), and Inari Medical (NARI). These companies are all part of the "surgical & medical instruments" industry.
Alphatec (NASDAQ:ATEC) and Integra LifeSciences (NASDAQ:IART) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, community ranking, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.
66.4% of Alphatec shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 29.1% of Alphatec shares are held by insiders. Comparatively, 3.1% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Alphatec currently has a consensus price target of $22.89, suggesting a potential upside of 109.80%. Integra LifeSciences has a consensus price target of $36.80, suggesting a potential upside of 39.24%. Given Alphatec's stronger consensus rating and higher probable upside, analysts clearly believe Alphatec is more favorable than Integra LifeSciences.
In the previous week, Alphatec had 14 more articles in the media than Integra LifeSciences. MarketBeat recorded 27 mentions for Alphatec and 13 mentions for Integra LifeSciences. Alphatec's average media sentiment score of 0.25 beat Integra LifeSciences' score of 0.05 indicating that Alphatec is being referred to more favorably in the media.
Integra LifeSciences has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.
Alphatec has a beta of 1.48, suggesting that its share price is 48% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500.
Integra LifeSciences has a net margin of 2.63% compared to Alphatec's net margin of -37.45%. Integra LifeSciences' return on equity of 14.27% beat Alphatec's return on equity.
Integra LifeSciences received 122 more outperform votes than Alphatec when rated by MarketBeat users. Likewise, 57.90% of users gave Integra LifeSciences an outperform vote while only 56.68% of users gave Alphatec an outperform vote.
Summary
Integra LifeSciences beats Alphatec on 10 of the 18 factors compared between the two stocks.
Get Alphatec News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alphatec Competitors List
Related Companies and Tools
